#triple-negative breast cancer

Study Points Immune System at Triple-Negative Breast Cancer

Keytruda plus chemotherapy reduced the risk of disease progression or death by 35% compared with chemotherapy alone in certain people.

Keytruda plus chemotherapy reduced the risk of disease progression or death by 35% compared with chemotherapy alone in certain people.

Anne Boyer, a poet and essayist, writes about her experience with triple-negative breast cancer in “The Undying.”

Keytruda improves response rates for hard-to-treat breast cancer, but Tecentriq falls short.

A study looked at circulating tumor DNA as a biomarker for health outcomes among women with triple-negative breast cancer.

An annual campaign to increase awareness of the disease.

National Mammography Day is observed the 3rd Friday of October since 1993.

Adding immunotherapy to preoperative chemotherapy increased the likelihood of complete remission.

When therapist Clare Reed, of Dublin, was diagnosed with breast cancer, she used her therapeutic skills to change her own life.

“Don’t eat me” proteins are “like invisibility cloaks for the cancer,” preventing white blood cells from detecting and devouring tum...

Until now, there had been little opportunity to note the effects of anti-estrogen therapy on brain metastases resulting from breast cancer.

Tecentriq plus Abraxane was approved under accelerated approval based on progression-free survival.

ORR, PFS, TTP…we help you sort out what they mean.